Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin Cellular Resistance in AIS
NCT02829476Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2010
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Intracellular cyclic adenosine monophosphate dosage. Started Mar 2010; status: completed.
Beyond the preview
Go deeper on NCT02829476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02829476.